Coronavirus: Medlife launches at-home COVID-19 testing in select cities
E-health platform Medlife on Tuesday said it has partnered with accredited labs to launch at-home testings for COVID-19 in select cities, and plans to expand it going forward.
The price of a test is set at Rs 4,500 and will be conducted by labs authorised by the Indian Council of Medical Research (ICMR), Medlife said in a statement.
It added that the tests will be conducted using real-time PCR methodology.
Currently, the coronavirus testing service is available in Mumbai, Delhi, Noida, Ghaziabad, and Faridabad, it added. Gurugram and Pune will be added shortly, the startup said.
Medlife has also launched its e-consultation services and has empanelled 1,500 doctors across India for the same, the statement said.
E-consultation fees range from Rs 199 to Rs 599, and is currently available on Medlife’s Android app.
"We are partnering with ICMR-authorised labs to aid in the rapid scaling up of COVID-19 testing in India, an essential measure to check the spread of the virus in the country," Medlife Co-founder and CEO Ananth Narayanan said.
As the startup plays its part in the nation's fight against the pandemic, it is determined to ensure that regular and chronic patients continue to receive quality healthcare services, he added.
"The launch of our e-consultation service is aimed at encouraging vulnerable and at-risk patients, especially ones with chronic diseases, to direct their concerns to our highly-trained doctors from the safety and comfort of their homes", Narayanan said.
The labs with which the startup has partnered are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), a constituent board of the Quality Council of India.
Founded in November 2014, Medlife currently services 29 states, 4,000 cities, and 20,000 pin codes in India, fulfilling over 30,000 deliveries daily.
(Disclaimer: Additional background information has been added to this PTI copy for context)
Edited by Suman Singh